| Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc (NCT00289731) | GlaxoSmithKline | 2003-11-24 |
| Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months (NCT00197236) | GlaxoSmithKline | 2003-11-11 |
| Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared (NCT00197184) | GlaxoSmithKline | 2003-11-01 |
| GW572016 For Treatment Of Refractory Metastatic Breast Cancer (NCT00062686) | GlaxoSmithKline | 2003-11-01 |
| Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease (NCT00549146) | GlaxoSmithKline | 2003-11-01 |
| Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine. (NCT00263679) | GlaxoSmithKline | 2003-11-01 |
| Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab (NCT00240578) | GlaxoSmithKline | 2003-11-01 |
| Depression And Bipolar Disorder (NCT00274677) | GlaxoSmithKline | 2003-11-01 |
| Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment (NCT00090103) | GlaxoSmithKline | 2003-11-01 |
| Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults (NCT00120848) | GlaxoSmithKline | 2003-11-01 |
| A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer (NCT00073008) | GlaxoSmithKline | 2003-11-01 |
| Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy. (NCT00422955) | GlaxoSmithKline | 2003-11-01 |
| Dyslipidemia Study Investigating The Increase In "Good Cholesterol" (NCT00169559) | GlaxoSmithKline | 2003-11-01 |
| A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics (NCT00067951) | GlaxoSmithKline | 2003-10-17 |
| Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects (NCT00499707) | GlaxoSmithKline | 2003-10-08 |
| Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children (NCT00197015) | GlaxoSmithKline | 2003-10-06 |
| Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age. (NCT00750360) | GlaxoSmithKline | 2003-10-03 |
| Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04 (NCT00731393) | GlaxoSmithKline | 2003-10-01 |
| Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults (NCT01767402) | GlaxoSmithKline | 2003-10-01 |
| LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers (NCT00240526) | GlaxoSmithKline | 2003-10-01 |
| Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course (NCT01457547) | GlaxoSmithKline | 2003-10-01 |
| Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg) (NCT00240539) | GlaxoSmithKline | 2003-10-01 |
| Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels (NCT00062790) | GlaxoSmithKline | 2003-10-01 |
| Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy (NCT00264680) | GlaxoSmithKline | 2003-10-01 |
| Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab (NCT00240591) | GlaxoSmithKline | 2003-10-01 |
| Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. (NCT00069836) | GlaxoSmithKline | 2003-10-01 |
| Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers (NCT00240500) | GlaxoSmithKline | 2003-10-01 |
| Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population. (NCT00307008) | GlaxoSmithKline | 2003-10-01 |
| Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). (NCT00352963) | GlaxoSmithKline | 2003-09-30 |
| Seasonal Affective Depression (SAD) Study (NCT00069459) | GlaxoSmithKline | 2003-09-23 |
| Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) (NCT01855711) | GlaxoSmithKline | 2003-09-18 |
| Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age (NCT00197002) | GlaxoSmithKline | 2003-09-11 |
| Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). (NCT00792623) | GlaxoSmithKline | 2003-09-08 |
| Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years (NCT00196950) | GlaxoSmithKline | 2003-09-01 |
| GW406381 In Patients With Peripheral Nerve Injury (NCT00279032) | GlaxoSmithKline | 2003-09-01 |
| Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa (NCT00383903) | GlaxoSmithKline | 2003-09-01 |
| Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine (NCT00197171) | GlaxoSmithKline | 2003-09-01 |
| Study of Salmeterol (SN408D) for Adult Asthma (NCT00950794) | GlaxoSmithKline | 2003-09-01 |
| A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma. (NCT01499446) | GlaxoSmithKline | 2003-09-01 |
| Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer (NCT00065182) | GlaxoSmithKline | 2003-08-14 |
| A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. (NCT00140673) | GlaxoSmithKline | 2003-08-05 |
| Post Market Surveillance for Infanrix™ (NCT00908115) | GlaxoSmithKline | 2003-08-01 |
| OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction (NCT00064428) | GlaxoSmithKline | 2003-08-01 |
| Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™ (NCT01061541) | GlaxoSmithKline | 2003-08-01 |
| Clinical Study Of Schizophrenia in Both Men and Women (NCT00071747) | GlaxoSmithKline | 2003-08-01 |
| A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome (NCT00363857) | GlaxoSmithKline | 2003-08-01 |
| Bipolar Study in Adults at Least 18 Years of Age (NCT00067938) | GlaxoSmithKline | 2003-08-01 |
| Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia (NCT00969072) | GlaxoSmithKline | 2003-08-01 |
| Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine (NCT00757770) | GlaxoSmithKline | 2003-08-01 |
| A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique. (NCT00197041) | GlaxoSmithKline | 2003-07-01 |
| A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. (NCT00317174) | GlaxoSmithKline | 2003-07-01 |
| AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus (NCT00241605) | GlaxoSmithKline | 2003-06-25 |
| Depression Study In Elderly Patients (NCT00067444) | GlaxoSmithKline | 2003-06-01 |
| Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria (NCT00519467) | GlaxoSmithKline | 2003-06-01 |
| Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy (NCT00067561) | GlaxoSmithKline | 2003-06-01 |
| Lethargic Depression Study (NCT00064467) | GlaxoSmithKline | 2003-06-01 |
| SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease (NCT00361959) | GlaxoSmithKline | 2003-06-01 |
| Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa (NCT00381472) | GlaxoSmithKline | 2003-06-01 |
| Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy (NCT00067457) | GlaxoSmithKline | 2003-06-01 |
| Study Of Generalized Anxiety Disorder (NCT00135525) | GlaxoSmithKline | 2003-05-01 |
| Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. (NCT00544271) | GlaxoSmithKline | 2003-05-01 |
| Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) (NCT00148902) | GlaxoSmithKline | 2003-04-28 |
| Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine (NCT00146835) | GlaxoSmithKline | 2003-04-01 |
| Michelangelo - Oasis 5 (NCT00139815) | GlaxoSmithKline | 2003-04-01 |
| Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) (NCT01294605) | GlaxoSmithKline | 2003-04-01 |
| Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab (NCT00062894) | GlaxoSmithKline | 2003-04-01 |
| A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma (NCT00315731) | GlaxoSmithKline | 2003-03-31 |
| A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer (NCT00058526) | GlaxoSmithKline | 2003-03-20 |
| Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine (NCT00127855) | GlaxoSmithKline | 2003-03-01 |
| An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder (NCT00057213) | GlaxoSmithKline | 2003-03-01 |
| An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder (NCT00057239) | GlaxoSmithKline | 2003-03-01 |
| An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder (NCT00057226) | GlaxoSmithKline | 2003-03-01 |
| 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age (NCT00129116) | GlaxoSmithKline | 2003-03-01 |
| "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk (NCT00056407) | GlaxoSmithKline | 2003-03-01 |
| Bipolar Disorder Study for Men and Women (NCT00056277) | GlaxoSmithKline | 2003-02-27 |
| GSK BHR Study (Sont) (NCT00920543) | GlaxoSmithKline | 2003-02-01 |
| A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy (NCT00053638) | GlaxoSmithKline | 2003-02-01 |
| A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children (NCT00297206) | GlaxoSmithKline | 2003-01-25 |
| HerpeVac Trial for Young Women (NCT00057330) | GlaxoSmithKline | 2003-01-14 |
| Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors (NCT00085878) | GlaxoSmithKline | 2003-01-01 |
| Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies. (NCT00169546) | GlaxoSmithKline | 2003-01-01 |
| Effects Of Antidepressants On Sexual Functioning In Adults (NCT00051272) | GlaxoSmithKline | 2003-01-01 |
| Effects of Antidepressants on Sexual Functioning (NCT00051259) | GlaxoSmithKline | 2003-01-01 |
| Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers (NCT00135564) | GlaxoSmithKline | 2003-01-01 |
| Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy (NCT01916720) | GlaxoSmithKline | 2003-01-01 |
| GSK BHR Study (Sont - Second Study) (NCT01324362) | GlaxoSmithKline | 2003-01-01 |
| Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF) (NCT00344513) | GlaxoSmithKline | 2002-12-16 |
| Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies. (NCT00370591) | GlaxoSmithKline | 2002-12-01 |
| A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B (NCT00857675) | GlaxoSmithKline | 2002-12-01 |
| Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer (NCT00061308) | GlaxoSmithKline | 2002-12-01 |
| A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder (NCT00048204) | GlaxoSmithKline | 2002-11-04 |
| Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety (NCT00263692) | GlaxoSmithKline | 2002-11-01 |
| A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients (NCT00453778) | GlaxoSmithKline | 2002-11-01 |
| CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. (NCT00479739) | GlaxoSmithKline | 2002-11-01 |
| A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine (NCT00109330) | GlaxoSmithKline | 2002-11-01 |
| The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain (NCT00376454) | GlaxoSmithKline | 2002-11-01 |
| Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants (NCT00291967) | GlaxoSmithKline | 2002-11-01 |
| Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. (NCT00051103) | GlaxoSmithKline | 2002-10-01 |
| Study In Patients With Insulin Resistance (NCT00197132) | GlaxoSmithKline | 2002-10-01 |
| Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone. (NCT00306696) | GlaxoSmithKline | 2002-10-01 |